Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

Q: What does CUSIP G7709Q104 represent in this 13F holders report?

CUSIP G7709Q104 is the security identifier for RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share in Q1 2022?

272 institutional investors reported RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share for Q1 2022. Use the holders table for investor-level position and value details.

CUSIP: G7709Q104

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Class A Ordinary Shares, par value $0.0001 per share
Shares outstanding: 424,966,351
Total 13F shares: 270,383,631
Share change: +2,206,105
Total reported value: $10,536,275,796
Put/Call ratio: 10%
Reported price per share: $38.96
Number of holders: 272
Value change: +$82,755,109
Number of buys: 175
Number of sells: 91

Security key

G7709Q104

Report period

Q1 2022

Institutions

272

Top holders

RPRX full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2022 Previous quarter: Q4 2021 Royalty Pharma plc SEC filings Royalty Pharma plc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP G7709Q104

Newer quarter: Q2 2022 Previous quarter: Q4 2021

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

MORGAN STANLEY

13D/G signal

—

Evidence rows

Latest as of

31 Dec 2021

13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Rank 1 holder

MORGAN STANLEY

13F

Ownership: 13%
Position: $2.24B

13F

Rank 2 holder

VANGUARD GROUP INC

13F

Ownership: 7%
Position: $1.18B

13F

Rank 3 holder

ADAGE CAPITAL PARTNERS GP, L.L.C.

13F

Ownership: 5.8%
Position: $989.98M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F Company 13F	13%	$2,240,794,000 56,230,690 shares	—	31 Dec 2021
VANGUARD GROUP INC	13F Company 13F	7%	$1,181,017,000 29,636,565 shares	—	31 Dec 2021
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F Company 13F	5.8%	$989,982,000 24,842,715 shares	—	31 Dec 2021
FMR LLC	13F Company 13F	5.2%	$879,880,000 22,079,785 shares	—	31 Dec 2021
BlackRock Finance, Inc.	13F Company 13F	3.9%	$666,107,000 16,715,324 shares	—	31 Dec 2021
VIKING GLOBAL INVESTORS LP	13F Company 13F	2.4%	$411,068,000 10,315,378 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

272

270,383,631

Rows available

272

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

254

Q1 2022 holders

272

Holder diff

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 value	Q1 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend